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Abstract 
Maf1 protein is a global negative regulator of Pol III transcription conserved from yeast to 
man. We report that phosphorylation of Maf1 by casein kinase II (CK2), a highly evolutionarily 
conserved eukaryotic kinase, is required for efficient Pol III transcription. Both recombinant human 
and yeast CK2 were able to phosphorylate purified human or yeast Maf1, indicating that Maf1 can 
be a direct substrate of CK2. Upon transfer of Saccharomyces cerevisiae from repressive to 
favorable growth conditions, CK2 activity is required for the release of Maf1 from Pol III bound to 
a tRNA gene and for subsequent activation of tRNA transcription. In a yeast strain lacking Maf1, 
CK2 inhibition showed no effect on tRNA synthesis, confirming that CK2 activates Pol III via 
Maf1. Additionally, CK2 was found to associate with tRNA genes, and this association is enhanced 
in absence of Maf1, especially under repressive conditions. These results corroborate the previously 
reported TFIIIB-CK2 interaction and indicate an important role of CK2-mediated Maf1 
phosphorylation in triggering Pol III activation. 
\body 
Introduction 
RNA polymerase (Pol) III is responsible for the transcription of some 300 different genes in 
yeast (class III genes), mostly tRNA genes (1-3). In-depth analyses of the yeast Pol III transcription 
system have revealed a cascade of protein-DNA and protein-protein interactions leading to the 
recruitment of Pol III to its target tRNA genes: binding of the six-subunit TFIIIC factor to the 
intragenic promoter, TFIIIC-directed recruitment and assembly of the three subunits of TFIIIB 
(TBP, Brf1 and Bdp1) and subsequent recruitment of the 17-subunit Pol III enzyme (4). High rate 
of tRNA transcription is achieved through many rounds of re-initiation by Pol III on stable DNA-
bound complexes of the initiation factor TFIIIB (5, 6) 
Pol III is under control of the general negative regulator Maf1 (7, 8), which binds to Pol III- 
specific subcomplex C82/34/31 that is required for transcription initiation (9). In the repressive 
complex Maf1 impairs recruitment of Pol III to a complex of promoter DNA with the initiation 
factors TFIIB and thus prevents closed-complex formation (6, 9). Maf1 is essential for repressing 
Pol III transcription in yeast and mediates several signaling pathways (10). In addition to the down-
regulation that occurs normally in the stationary phase, Pol III repression accompanying starvation, 
respiratory growth as well oxidative and replication stress also requires Maf1 (11-13). Maf1 inhibits 
Pol III transcription via a mechanism that depends on the dephosphorylation and nuclear 
accumulation of Maf1 followed by its physical association with Pol III at Pol III-transcribed genes 
genome-wide (8, 14). In contrast Maf1 phosphorylation occurs in favorable growth conditions and 
is linked to cytoplasmic localization of Maf1 (8, 15). 
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Maf1 was recently found to be phosphorylated by protein kinases PKA (16, 17), Sch9 (18-
20) and TORC1 (21), but participation of other kinases in Maf1 regulation is conceivable. First, 
phosphorylation by PKA prevents Maf1 nuclear import (17) but does not seem to be involved in 
direct regulation of Maf1 activity by carbon source or nutrient availability (11, 19). Second, tRNA 
transcription levels were not significantly changed either by Sch9- or TORC1-dependent 
phosphorylation of Maf1 (18, 19, 21). Finally, mutating the potential phosphorylation sites for Sch9 
and PKA still allowed regulation of Pol III indicating another critical factor (18, 19). The results 
presented here point to CK2 as a possible missing kinase. 
Casein kinase 2 (CK2), a vital, pleiotropic and highly conserved serine/threonine 
phosphotransferase is involved in transcription-directed signaling, gene control, and cell cycle 
regulation and has been implicated in critical cellular processes such as proliferation, apoptosis, 
differentiation, and transformation (22). CK2 is mostly present as a tetramer composed of two 
catalytic and two regulatory subunits (in yeast Cka1/2 and Ckb1/2, respectively). The regulatory 
subunits stimulate the catalytic subunits, stabilize the CK2 heterotetramer, and act as a scaffold for 
specific kinase partners (23) The enzyme is expressed constitutively at a modest level, is 
predominantly in the nucleus, where it is a component of several chromatin-associated complexes, 
and is predicted to phosphorylate a broad spectrum of nuclear as well as cytoplasmic proteins 
involved in multiple aspects of gene expression (24). 
It has been shown previously that CK2 is a positive regulator of Pol III transcription in yeast 
and humans. CK2 is stably associated with TFIIIB (25, 26) and phosphorylates subunits TBP in 
yeast, and Brf1 and Bdp1 in humans (26, 27). CK2 activity is required for assembly of Pol III 
transcription initiation complex on gene promoters in human cells (26, 28). Surprisingly, 
phosphorylation of Bdp1 by CK2 decreases Pol III activity during mitosis in human cells (29). 
We previously demonstrated that nuclear localization of Maf1 is not sufficient for Pol III 
repression but must be accompanied by Maf1 dephosphorylation to ensure interaction with Pol III 
and inhibition of tRNA transcription (15). We also concluded that phosphorylation of Maf1 is 
essential for its export out of the nucleus. We thus postulated the existence of a nuclear kinase 
which would phosphorylate Maf1, thereby breaking its interaction with the Pol III complex and 
allowing activation of tRNA transcription. Here we show that CK2 is the postulated kinase involved 
in this process. 
 
Results 
Maf1 is phosphorylated by CK2 kinase. CK2 is the evolutionarily conserved kinase involved in 
numerous pathways regulating gene expression. We reasoned that it might also be involved in Maf1 
regulation. To determine effect of CK2 inactivation on Maf1 phosphorylation state in vivo, we took 
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advantage of yeast strains with decreased catalytic activity of CK2 (30). In wild-type (wt) cells 
grown in glucose-containing medium, two phosphorylated forms of Maf1 are observed in SDS-
PAGE as slower migrating additional bands. This pattern of Maf1 phosphorylation was variably 
altered in the single cka1- and double cka1- cka2ts mutants. Inhibition of CK2 activity following 
shift to an elevated temperature resulted in lack of Maf1 phosphorylation of Maf1 in cka1- cka2ts 
cells unlike in wt or cka1- strains where we observed no change or only a slight decrease in Maf1 
phosphorylation, respectively (Fig. 1). 
Because active CK2 have been shown to bind directly TBP subunit of TFIIIB (Ghadivel and 
Schultz, 2001), we used co-immunoprecipitation experiments to test whether Maf1 was able to 
interact with CK2 catalytic subunit. Crude extracts were prepared from Cka2-HA tagged cells and 
control wild type cells with untagged Cka2. Cells were grown in glucose medium, transferred to 
pre-warmed glycerol medium and harvested after 3 hours. HA-tagged Cka2 was 
immunoprecipitated from cell extracts with magnetic beads coated with anti-HA antibodies and the 
immunoprecipitates were examined for the presence of Maf1 by immunoblotting. As shown in 
Figure 2, Cka2 was efficiently immunopurified from crude extracts (compare lane 1 with lane 2 and 
lane 3 with lane 4) and hyperphosphorylated form Maf1 was selectively co-immunoprecipitated 
with HA-tagged Cka2 from glucose cells (compare lane 5 with control lane 7). Maf1 was also 
detectable in Cka2-HA immune complexes from glycerol cells (compare lane 6 with control lane 8). 
This result indicates that Maf1 and Cka2, catalytic subunit of CK2, interact with each other. 
Next we asked if Maf1 could be directly phosphorylated by CK2 in vitro. Recombinant S. 
cerevisiae Maf1 expressed in Escherichia coli was incubated with [32P]-ATP and purified yeast 
TAP tagged CK2. Analysis of the reaction outcome by SDS-PAGE and autoradiography indicated 
that Maf1 was phosphorylated (Fig. 3). Consistent with the idea that CK2 is responsible for the 
observed phosphorylation of recombinant Maf1, incorporation of [32P]-ATP was completely 
blocked by tetrabromobenzotriazol (TBBt), a specific CK2 inhibitor, (31). 
To extend the results obtained using recombinant Maf1, we studied phosphorylation of yeast 
Maf1 and human Maf1 with highly purified human CK2. Human recombinant Maf1, expressed in 
insect cells, was mixed with purified human CK2 alpha catalytic subunit in the presence of [32P]-
ATP resulting in successful phosphorylation (Fig. S1). Notably, human CK2 also phosphorylated 
yeast Maf1. Therefore the process of Maf1 phosphorylation by CK2 is evolutionarily conserved. 
Having established that CK2 phosphorylates Maf1 in vitro, we next asked what the specific 
phosphorylation sites are. The mass-spectrometry analysis of CK2-phosphorylated recombinant 
yeast Maf1 revealed phosphorylation of serine S388 and at least one phosphorylation site located in 
serine tract S159-162 (Table S1, repeated experiments 1-3). Importantly, parallel mass spectrometry 
analysis of Maf1 immunopurified from cells exponentially growing in glucose identified 
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phosphorylation of both one and two serines within S159-162 tract (Table S1, experiments 4-6). 
Unfortunately in this analysis S388-containing peptide was not detected thus we were not able to 
confirm modification at this site. Beside S159-162 sites assigned presumably to CK2, several 
PKA/Sch9–specific phosphorylation sites were also identified in Maf1 from glucose cells 
confirming results published previously (17, 19) (Table S1, repeated experiments 4-6). All possible 
phosphorylation sites detected in CK2-phosphorylated recombinant Maf1 were inactivated resulting 
in 5StA mutant (S159A, S160A, S161A, S162A, S388A). Without a doubt Maf1 phosphorylation in 
vivo was not observed in 5StA mutant (Fig. 4). Interestingly, concurrent western analysis of 1StA 
(S388A) shows no effect on Maf1 phosphorylation while analysis of 4StA (S159A, S160A, S161A, 
S162A) mutant revealed differently migrating forms of Maf1 (Fig. 4). Thereby contribution of both, 
S159-162 and S388 CK2- phosphorylation sites seems to be similarly important for Maf1 function. 
Notably, the lack of Maf1 phosphorylation in 5StA mutant seems not to be an effect of protein 
miss-folding since it complemented growth phenotype of maf1- (Fig. S2A). Moreover, 
inactivation of CK2-phosphorylation sites in Maf1 somewhat decreased Pol III activity (Fig. S2B). 
 
CK2 is necessary for regulation of Maf1 activity by carbon source. As shown previously, Maf1 
is phosphorylated in response to a shift from respiratory conditions to fermentative growth (15). To 
examine a possible role of CK2 in Maf1 phosphorylation in response to carbon source, we used the 
single cka1- and double cka1- cka2ts mutants. Cells exponentially growing in a rich glucose 
medium (YPD) were transferred to a nonfermentable glycerol medium (YPGly) at 30°C then back 
to the glucose medium and incubated at 37
o
C. Gradual phosphorylation of Maf1 at 37
o
C was 
observed in the control, but phosphorylation was less efficient in cka1- and did not occur in the 
cka1- cka2ts mutant cells (Fig. 5A). Maf1 phosphorylation was also inhibited when wild-type cells 
were transferred from YPGly to YPD supplemented with TBBt (Fig. 5B). Altogether these results 
suggest participation of CK2 in Maf1 phosphorylation during the switch between respiration and 
fermentation. 
Noteworthy, TBBt only modestly affected Maf1 phosphorylation in cells growing 
exponentially in YPD (Fig. S3A). Differences observed between the effects of TBBt and mutations 
in catalytic subunits of CK2 on Maf1 phosphorylation in cells exponentially growing in YPD (Fig. 
S3 A and B) raised further ideas. First, deletion of a single catalytic subunit of CK2 did not 
significantly change Maf1 phosphorylation (Fig. 1 and Fig. S3B), indicating a functional 
redundancy of the two catalytic subunits. Second, specificity of TBBt towards the Cka1 and Cka2 
catalytic subunits varied; TBBt precluded phosphorylation of Maf1 only in cka2- cells (Fig. S3B), 
suggesting that Cka1 is more sensitive to this inhibitor.  
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The correlation of Maf1 phosphorylation and export to the cytoplasm observed previously 
raised the question of whether a decrease of CK2 activity would concomitantly compromise Maf1 
exit from the nucleus. Immunofluorescence microscopy analysis showed that the Maf1-specific 
signal was uniformly distributed throughout the cell in YPD medium and concentrated in the 
nuclear compartment in YPGly, which was accompanied by Maf1 dephosphorylation (Fig. S4, 
compare lanes 1 and 2). Upon transfer of the cells back to YPD, supplemented with DMSO for 
control, Maf1 was re-phosphorylated and relocated to the cytoplasm (lane 3) but remained in the 
dephosphorylated state in the nucleus when TBBt was added (lane 4). The effect of TBBt was 
reversible since Maf1 was re-phosphorylated and relocated out of the nucleus following TBBt 
removal (lane 6). We thus concluded that phosphorylation by CK2 mediates Maf1 export to the 
cytoplasm following transfer of yeast from a medium with a nonfermentable carbon source to one 
with glucose. 
 
CK2 controls Maf1 association with tRNA genes. Previous work implicated Maf1 association 
with tRNA genes in a nutrient-dependent manner (8, 21). Since tRNA transcription is also regulated 
by carbon metabolism (11), we monitored carbon source-dependent Maf1 occupancy on class III 
genes and its dependence on CK2. Chromatin immunoprecipitation (ChIP) analyzed by real-time 
quantitative PCR showed moderate but significant enrichment of Maf1 on tRNA genes when 
glucose-grown cells were harvested in exponential growth phase (Fig. 6). In glycerol medium, 
however, the Maf1 occupancy on tRNA genes increased significantly. Strikingly, we were unable to 
detect Maf1 on 5S rDNA chromatin in either condition. Shifting the cells back to glucose medium 
led to the dissociation of Maf1 from tRNA genes and, significantly, supplementation of the medium 
with the TBBt inhibitor impaired this dissociation dramatically. Altogether, these data suggest that 
CK2 mediates dissociation of Maf1 from tRNA genes following transfer of yeast from 
nonfermentable (glycerol) to fermentable (glucose) growth conditions. 
To investigate the possible effect of CK2 activity on Maf1 interaction with Pol III we used 
yeast cells expressing HA-tagged Rpc160, the largest Pol III subunit. Pol III was immunopurified 
from crude extracts and the immunoprecipitate was analyzed by Western blot (Fig. 6B). Equal 
amounts of Rpc160 were precipitated from yeast grown in glucose and glycerol media, whereas the 
levels of co-immunopurified Maf1 varied depending on growth conditions. In glucose medium, 
little Maf1 is bound to Pol III (Fig. 6B, lane 1), while in the glycerol medium the amount is over 
nine fold higher (Fig. 6B lane 2 and Fig 6C). Maf1 dissociated from the Pol III complex when cells 
were shifted back to the glucose medium supplemented with DMSO (lane 3), but this dissociation 
was over five fold less pronounced when the medium was supplemented with TBBt (Fig. 6B lane 4 
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and Fig 6C). We concluded that CK2 activity is required to release Maf1 from the Pol III complex 
and tRNA genes upon exit from nonfermentable to fermentable growth conditions. 
 
Maf1 mediates CK2 signal transduction to Pol III. Knowing that CK2 regulates Maf1 interaction 
with Pol III and its occupancy at tRNA genes we asked how Maf1 phosphorylation by CK2 
influences Pol III transcription activity in vivo. We took advantage of the fact that yeast lacking 
Maf1 are viable. Total RNA was isolated from wt and maf1- cells grown in glucose medium, 
transferred to glycerol medium and transferred back to glucose medium supplemented or not with 
TBBt. To estimate the amounts of newly synthesized tRNA, we used an intron probe 
complementary to pre-tRNA
Leu
 (Fig. 7). Quantification of the intron-containing tRNA precursor 
revealed repression of Pol III activity in the wild-type strain but not in maf1- upon transition of 
exponentially growing cells from glucose to glycerol, consistent with our previously published data 
(11, 15). After transfer back to the glucose medium, the pre-tRNA transcript levels in wild-type and 
maf1- returned nearly to those before shifting cells to the glycerol medium (compare lanes 3, 7 
and 1, 5). In contrast, transition to the glucose medium supplemented with TBBt precluded pre-
tRNA derepresion in the wild-type strain, whereas in the maf1- strain the pre-tRNA level was 
similar in the medium without TBBt (compare lanes 3, 7 and 4, 8). Altogether these data suggest 
that CK2 activates Pol III transcription via Maf1 phosphorylation. 
 
Inhibition of Pol III transcription by mutations in catalytic subunits of CK2 is less effective in 
maf1- strain. Earlier data showed that the Pol III transcription activity was very low in cka1- 
cka2
ts 
mutant cells even at permissive growth temperature (27, 30). To extend these studies to Maf1 
we constructed cka1- cka2ts maf1- triple mutant and examined the amounts of newly synthesized 
tRNA using the intron probe complementary to pre-tRNA
Leu
. Total RNA was isolated from the 
cka1- cka2ts and cka1- cka2ts maf1- mutant cells grown in glucose medium and transferred to 
the same medium pre-warmed to 37C (non-permissive temperature) (Fig. 8). Quantification of 
Northern blot revealed that deletion of the MAF1 gene in the cka1- cka2ts double mutant led to 
increased pre-tRNA
Leu
 synthesis both at the permissive and non-permissive temperatures. We posit 
that cka1- cka2ts double mutation leads to the constitutive presence of repressive 
hypophosphorylated forms of Maf1 (as shown in Fig. 1) that inhibit Pol III transcription both at 
30C and 37C.  
 
CK2 associates with tRNA genes in Maf1-sensitive manner. The previously reported CK2 co-
purification with TFIIIB (25) prompted us to investigate the presence of CK2 at class III genes. We 
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used a control wild-type strain and an isogenic maf1- mutant, both expressing Myc-tagged  
catalytic subunit of CK2 (Cka1-Myc) to perform ChIP analysis followed by real-time quantitative 
PCR. Slight but significant association of CK2 with tRNA
Leu
 and tRNA
Trp
 genes (2-4 fold above 
background) was observed for the wild type strain. The occupancy of CK2 at tRNA genes was, 
however, significantly increased in the maf1- strain, especially when cells were grown under 
repressive conditions in glycerol medium (7-8 fold above background). To our surprise, little or no 
association of Cka1-Myc was found with other class III genes tested - RDN5 (5S rRNA gene), 
SCR1 and SNR6 - in the wild type and maf1- strains, regardless of the growth conditions (Fig. 9). 
These data suggest that CK2 is present at some Pol III-transcribed genes but the level of this 
occupancy is modulated by Maf1. 
 
Discussion 
In this work we present evidence that Maf1 is phosphorylated by CK2 kinase. We show that 
Maf1 phosphorylation by CK2 contributes directly to activation of Pol III transcription by 
stimulating Maf1 dissociation from the Pol III complex and from tRNA genes.  
We found that yeast Maf1 is phosphorylated by CK2 on S388 and on at least two residues 
within serine tract S159-S162. Significantly, these sites are located in two highly flexible regions of 
Maf1. S388 is located in the C-terminal tail whereas S159-S162 lie in a mobile linker separating 
two conserved, highly structured A and BC fragments. Notably, sites known to be phosphorylated 
in Maf1 by PKA/Sch9 are S177-180 (17, 19) are located in the second serine tract located between 
the A and BC boxes (Fig S5). Human Maf1 has the same organization of two structured A and BC 
regions separated by a linker, which, however, is shorter and not homologous to the yeast one. 
Human Maf1 is phosphorylated by mTOR, and, significantly, the phosphorylation sites are within 
the linker region (32-34). Thus, the presence of phosphosites in the region separating the A and BC 
fragments has been conserved from yeast to humans, even though the specific amino acid sequence 
has not. The phosphorylation state of the linker therefore appears to be a key factor that changes the 
distance between the A and BC regions modulating their interaction and Maf1 association with Pol 
III, supporting the hypothesis presented by Gajda et al (35). Here we propose that CK2 
phosphorylation promotes Maf1 dissociation from Pol III in yeast.  
Because CK2 activity is required for cell cycle progression at G1-S and G2/M (30), we asked 
whether the observed defect of Maf1 phosphorylation in CK2-deficient cells is an indirect effect of 
cell cycle blockage or is a direct result of the lowered CK2 activity. The relationship between 
checkpoint signaling and regulation of tRNA synthesis was analyzed extensively by a recent study 
showing that neither normal progression trough S phase nor alpha-factor-mediated G1 arrest or 
G2/M arrest by nocodazole are associated with alterations in tRNA transcription (13). These results 
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indicate that the Maf1-mediated effect on tRNA transcription correlated with CK2 depletion cannot 
be attributed to cell-cycle defects.  
Yeast cells synthesize 3–6 million molecules of tRNA every cell cycle at a rate of 2–4 
transcripts/gene/s (6). This high rate of transcription is achieved through many rounds of Pol III 
reinitiation on stable DNA-bound complexes of the initiation factor TFIIIB. Studies in yeast have 
shown that the CK2 phosphorylation of TBP is required for efficient TFIIIB recruitment to Pol III 
promoters in unstressed cells (25). The rate of re-initiation is increased by facilitated recycling, a 
process of repeated reloading of the polymerase on a given transcription unit. However, when 
nutrients become limiting, stress conditions are encountered or yeast are transferred from glucose to 
a medium with non-fermentable carbon source, Pol III transcription is rapidly repressed through the 
action of Maf1 protein which, in the unphosphorylated state, binds to Pol III and obstructs 
transcription. Importantly, the Pol III repression by Maf1, at least that in response to DNA damage, 
is correlated with dissociation of CK2 catalytic subunits from the TFIIIB complex (25).  
Exactly how Maf1 is recruited to Pol III during ongoing transcription is unknown. Maf1 does 
not bind to a preassembled Pol III-Brf1-TBP-DNA initiation complex (6, 9). Moreover, a 
biochemical study clearly shows that Maf1 is not a Pol III inhibitor, as it prevents neither nucleic 
acid binding in the active center nor RNA synthesis (9). The Maf1 recruitment to Pol III could be 
brought about by an unknown event causing Pol III reposition and occurring after initiation step, 
during elongation or termination. According to a model presented by Riva, Carles and co-workers, a 
conformational change occurs in Pol III during a transitory pause at the elongation step prior 
termination and duration of this pause is controlled by the C37-C53 heterodimer (36). One 
interesting hypothesis could be that this pausing facilitates Maf1 binding.  
Here we examine the relationship between the Maf1-mediated repression and Pol III control 
by CK2. We demonstrate that phosphorylation of Maf1 by CK2 is critical for the release of Maf1 
from tRNA genes and for the high rate of Pol III transcription after a shift from repressing 
(glycerol) to optimal growth conditions (glucose). In repressing conditions, Maf1 is physically 
associated with the Pol III complex and with tDNA chromatin (8). Inhibition of CK2 hampers the 
dissociation of Maf1 from the Pol III complex and its export out of the nucleus as normally 
observed upon the shift from respiration to fermentation. Moreover, the dissociation of CK2 
catalytic subunit from Pol III chromatin is less efficient in the deletion strain maf1-∆. These results 
suggest that Maf1 assists the arrangement of CK2 complex thus preventing CK2-mediated 
phosphorylation of TBP during repression. 
We believe that CK2 controls the dynamic association of Maf1 with chromatin by assessing 
Pol III during re-initiation. Regardless of the growth conditions, Maf1 could be recruited to the Pol 
III complex with each transcription cycle, during elongation or termination. Our previous study 
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shows that a small amount of dephosphosphorylated Maf1 is Pol III-bound even in cells growing 
exponentially on glucose (8). We propose that this dephosphorylated nuclear Maf1 is associated 
with the re-initiating complex. Following termination, before the new transcription cycle of re-
initiating Pol III, Maf1 encounters CK2 bound to TFIIIB in promoter region. Under favorable 
growth conditions, CK2 phosphorylates Maf1, thus releasing it from Pol III and enabling re-
initiation. At the same time CK2 activates Pol III transcription by binding and phosphorylating 
TBP. Subsequent export of the phosphorylated Maf1 to the cytoplasm decreases its concentration in 
the nucleus lowering the probability of association with Pol III complex. Upon stress, the catalytic 
subunits of CK2 dissociate from TBP and CK2 becomes inactive. The Pol III-associated Maf1 
cannot be re-phosphorylated, remains with Pol III and re-initiation is not possible. Simultaneously 
TBP cannot be phosphorylated by CK2. Moreover, dephosphorylated Maf1 is imported from the 
cytoplasm to the nucleus to strengthen the Pol III repression. Altogether, the presented idea fits 
with, and even strengthens the model of Pol III regulation by CK2 proposed previously by Ghavidel 
and Schultz (25).  
Maf1 is regulated by a variety of pathways to adjust Pol III transcriptional rate to changing 
conditions. Besides CK2, three other kinases, PKA, Sch9 and TORC1, contribute to Maf1 
phosphorylation in yeast. A question arises about the sequence of their action and priority in Maf1-
dependent Pol III transcription regulation. We suggest that CK2 plays a major role by directly 
controlling Maf1-Pol III association whereas phosphorylation by other kinases mainly contributes 
to cellular localization of Maf1. According to our model presented above, the nuclear abundance of 
Maf1 supports the control of Pol III activity by CK2. Maf1 phosphorylation by PKA and Sch9 
contributes to excluding Maf1 from the nucleus, although inactivation of all potential Sch9 
phosphorylation sites resulted in constitutive Maf1 association with Pol III (19). Phosphorylation of 
Maf1 by TORC1 is thought to take place on chromatin in nucleoli and to contribute to Maf1 
regulation by excluding it from chromatin (21).  
Interestingly, TORC1 in yeast has been detected on 5S rRNA rather than on tRNA genes, in 
contrast to CK2 preferentially present on tRNA genes. The results presented here indicate that Maf1 
has a higher affinity for tRNA genes than for 5S rRNA genes. Initiation complexes assembled on 
tRNA genes compositionally different from complexes assembled on 5S rRNA genes, which could 
be the reason of the different Maf1 occupancy. The absence of Maf1 on 5S genes correlates with the 
lack an in vivo effect of Maf1 on 5S rRNA experession (7). Additionally MAF1 deletion failed to 
rescue the decreased 5S rRNA synthesis resulting from Sch9 inhibition in contrast to the effect on 
decreased tRNA synthesis (19). Interestingly, tRNA and 5S rRNA levels were also differentially 
affected by mutations in genes encoding the Pol III subunits C34, C31, C82, C53 and C160, which 
decreased of tRNA synthesis but did not alter the transcription of 5S rRNA (37-40).  
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In cells lacking Maf1, CK2 still binds to tRNA genes and this association is even increased 
upon the shift to repressive (glycerol) conditions. We propose that dissociation of the CK2 catalytic 
subunits from the TBP subunit of TFIIIB is precluded in the absence of Maf1. Therefore, one 
hypothesis is that Maf1 is required to block TFIIIB activation by CK2 thereby effecting Pol III 
repression. This raises the question of whether Maf1 may influence the CK2 holoenzyme at the 
heart of Pol III preinitiation complex.  
One unanswered but fundamental question is the mechanism of CK2 regulation. The 
presence of many discrete CK2 subpopulations is crucial in resolving the current conflicting views 
on whether CK2 is constitutively active or is modulated in response to specific stimuli is. Each local 
CK2 population may be regulated in a distinct manner to carry out its precise function(s). Most 
likely the CK2 activity is controlled through interactions of its regulatory subunits with other 
proteins. Apart from the transient formation of the holoenzyme with catalytic subunits of CK2 in 
humans, regulatory subunits can interact with at least 30 different proteins but is rapidly degraded 
when unassembled [for review see (22)]. In humans, CK2-mediated phosphorylation of p53 protein 
is regulated by the FACT complex (hSpt16 and SSRP1) (41), and Pin-1 protein inhibits 
phosphorylation of topoisomerase II by CK2 (42). We propose here a model in which Maf1 
regulates Pol III directly and also modulates CK2 activity towards TFIIIB. To confirm this 
conjecture, further studies are needed on how Maf1 influences the association of CK2 subunits with 
the TBP component of TFIIIB. 
CK2 is also present in the human Pol III complex and phosphorylates the TFIIIB subunits 
Brf1 (26) and Bdp1 (28). Our results indicate that human Maf1 can also be phosphorylated by CK2 
in vitro, although we have not tested this in vivo. Such evolutionary conservation suggests that 
phosphorylation of Maf1 by CK2 acting as a master switch of Pol III transcription is of fundamental 
importance. 
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Figure Legends 
 
Fig. 1. cka2
ts
 mutations affects Maf1 phosphorylation. Control strains (wt and cka1-) and 
isogenic thermosensitive double
 
cka1- cka2ts mutant (constructed by D. Glover) were grown to 
exponential phase in rich glucose medium (YPD Exp) at 30
o
C, transferred to pre-warmed rich 
glucose medium (YPD), incubated at 37
o
C and harvested as indicated. Crude extracts were prepared 
from cells by TCA-precipitation and analyzed using SDS-PAGE with a modified acrylamide-
bisacrylamide ratio followed by immunoblotting with polyclonal anti-Maf1 antibodies. Arrows 
indicate phosphorylated forms of Maf1. 
 
Fig. 2. Maf1 interacts with catalytic subunit of CK2. YPH499 strain expressing HA-tagged Cka2 
and WT control strain were grown in rich glucose medium to exponential phase (YPD), transferred 
to a nonfermentable glycerol medium (YPGly) and incubated for 3 h. Subsequently, cellular 
extracts were prepared and subjected to immunoprecipitation with magnetic beads coated with anti-
HA antibodies, followed by elution of bound proteins. Total cellular extracts (TOT), flow through 
(FT) and immunopurified proteins were analysed by SDS-PAGE and Western blot using anty-HA 
and anty-Maf1 antibodies. Arrow indicates hyperphosphorylated Maf1 and asterisk indicates 
hypophosphorylated Maf1. 
 
Fig. 3. Recombinant yeast Maf1 is phosphorylated by yeast CK2 in vitro. Recombinant S. 
cerevisiae Maf1 was expressed in Escherichia coli and purified by HIS-tag isolation. 
Autoradiogram shows [32P]-ATP-labeled products of reactions containing: 100 ng yeast TAP-tag 
purified CK2 and: 1 g casein (lane 0); increasing amounts of recombinant yeast Maf1 (0, 0.25, 0.5, 
1, 2 g – lanes 1-5); 2 g recombinant yeast Maf1 and 4% (v/v) DMSO (lane 6); 2 g recombinant 
yeast Maf1, 4% (v/v) DMSO and 10 M TBBt (lane 7). 
 
Fig. 4. Mutations of CK2 sites prevent Maf1 phosphorylation. Substitutions in MAF1 cloned in 
pRS315 vector were made using mutagenic PCR. Mutants 1StA (S388A), 4StA (S159A, S160A, 
S161A, S162A), 5StA (S159A, S160A, S161A, S162A, S388A) and corresponding wt were grown 
overnight in SC –leu medium, then in glucose rich medium to exponential phase (YPD Exp), 
transferred to glycerol medium for 3 h (YPGly) and again transferred to YPD for 3h. TCA-
precipitated proteins were examined by Western blot using anti-Maf1 antibody. 
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Fig. 5. CK2 is necessary for regulation of Maf1 activity by carbon source. Wild-type cells and 
isogenic mutants cka1- , cka2- and cka1- cka2ts were examined by Western blot using anti-
Maf1 antibody. Cells were grown to exponential phase in rich glucose medium (YPD Exp) at 30
o
C, 
transferred to glycerol medium (YPGly), incubated at 30
o
C for 3 h, then transferred to (A). pre-
warmed YPD, and incubated at 37
o
C (B). pre-warmed rich glucose medium containing 4% v/v 
DMSO or 200 M TBBt, and incubated at 30oC. Cells were harvested as indicated. 
 
Fig. 6. Dissociation of Maf1 from tRNA genes following transfer of yeast from nonfermentable 
glycerol growth conditions to glucose is dependent on CK2 activity. Relative occupancy of 
Maf1 at selected class III genes. Strain expressing Myc-tagged Maf1 was grown in rich glucose 
medium (YPD) to exponential phase and transferred to a nonfermentable glycerol medium 
(YPGly). Following 3 h incubation at 30
o
C, the culture was split in half; one part was transferred to 
YPD with 2% (v/v) DMSO and the second - to YPD with 200 M TBBt in DMSO. (A) Cross-
linked chromatin was immunoprecipitated with antibodies against Myc epitope, followed by 
quantitative real time PCR. Occupancies of Maf1 at tRNA-Leu, tRNA-Trp and 5S rRNA genes 
were measured relative to occupancy at 35S rRNA. (B) Cellular extracts were incubated with 
magnetic beads coated with anti-HA monoclonal antibody followed by elution of bound proteins 
and Western analysis with anti-HA and anti-Maf1 antibodies. (C) Quantification of the amounts of 
Maf1 immunopurified with Rpc160. Experiment was performed in triplicate to estimate standard 
deviation.  
 
Fig. 7. Pol III transcription is activated via Maf1 phosphorylation by CK2. (A) Northern blot 
analysis. Wild type and maf1- strains were grown in rich glucose medium (YPD) to exponential 
phase and transferred to a nonfermentable glycerol medium (YPGly). Following 3 h incubation at 
30
o
C the culture was split in half; one part was transferred to YPD with 4% (v/v) DMSO and the 
second - to YPD with 200 M TBBt in DMSO. RNA was isolated from cells and hybridized with 
tRNA
Leu
 intron and U3 probes. (B) Quantification of pre-tRNA
Leu
 transcript (upper band) 
normalized to U3 snoRNA transcript. Fold -change was calculated relative to expression in wild-
type cells grown in glucose medium.  
 
Fig. 8. Deletion of MAF1 gene restores Pol III transcription deficiency in cka1- cka2ts mutant 
 (A) Northern blot analysis. Isogenic mutants cka1- cka2t and cka1- cka2ts maf1- were grown in 
glucose medium (YPD) at 30C to exponential phase and transferred to YPD pre-warmed to 37C 
for 1 h. RNA was isolated from cells and hybridized with tRNA
Leu
 intron and U3 probes. (B) 
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Quantification of pre-tRNA
Leu
 transcript (upper band) normalized to U3 snoRNA transcript. Fold -
change was normalized to expression in cka1- cka2ts at 30C.  
 
Fig. 9. CK2 binds to tRNA in carbon source- and Maf1-sensitive manner. Relative occupancy 
of Cka1-Myc at selected class III genes. Strains wt and maf1-, both expressing Myc-tagged  
catalytic subunit of CK2 (Cka1-Myc) were grown in rich glucose medium (YPD) to exponential 
phase, transferred to a nonfermentable glycerol medium (YPGly) and incubated at 30
o
C for 40 min. 
Cross-linked chromatin was immunoprecipitated with antibodies against Myc epitope, followed by 
real time quantitative PCR. All occupancies are expressed relative to TEL15 region. The experiment 
was performed in triplicate to estimate S.D. 
